NCT01823835 2021-06-18A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast CancerGenentech, Inc.Phase 1/2 Terminated152 enrolled 42 charts